The trajectory of “medical cannabis” in Israel: Driving medicalization in different directions

Zarhin, Dana

doi:10.1016/j.drugpo.2020.102809

Cited by 9 publications

(2 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Following the sharp increase in the number of medical cannabis patients in Israel, together with the expected benefits of the consumption of medical cannabis, the phenomenon of diversion of medical cannabis between patients or for non-medical purposes has developed (Rozmann and Ne'eman-Haviv, 2023; Sznitman and Bretteville-Jensen, 2015; Zarhin, 2020). Despite knowledge about the existence of the phenomenon, there is no data on its prevalence.…”

Section: Introductionmentioning

confidence: 99%

Public perceptions of medical cannabis diversion: A legal and moral dilemma

Ne’eman-Haviv

Rozmann

2023

J Health Psychol

View full text Add to dashboard Cite

The study examined public perception in Israel of the severity of medical cannabis diversion, its morality, and normativeness. The sample included 380 participants who completed a quantitative questionnaire to respond to four scenarios about diverting medical cannabis to a person with/without a license and with/without a small payment (a 2×2 design). The findings show that although the participants received advance information about the severity of medical cannabis diversion as a drug trafficking offense, they perceived the severity of the offense as moderate, and as an act that is at least moderately moral and normative. The findings are explained based on moral theories. We discuss the implications of the findings in relation to the gap between public attitudes and legal policy.

show abstract

Section: Introductionmentioning

confidence: 99%

Public perceptions of medical cannabis diversion: A legal and moral dilemma

Ne’eman-Haviv

Rozmann

2023

J Health Psychol

View full text Add to dashboard Cite

show abstract

“…Cannabis sativa L., or Cannabis, is a member of the Cannabaceae family and is cultivated all over the world . It is one of the world’s oldest domesticated crops that had been used medically and nonmedically for thousands of years until, in the 1930s, it was classified as an illicit drug. − Informally, drug types of cannabis are commonly referred to as marijuana that is primarily grown and used for its medicinal or recreational psychoactive properties, while hemp strains are grown as a rich source of fibers and other materials. , There are more than 500 compounds identified from cannabis plants, among which over 100 are different phytocannabinoids. , The two most known and researched cannabinoids are Δ 9 -tetrahydrocannabinol (Δ 9 -THC) and cannabidiol (CBD). Δ 9 -THC is the primary psychoactive component of cannabis, the content level of which represents the key factor differentiating between hemp and medical cannabis.…”

Section: Introductionmentioning

confidence: 99%

Contents of Cannabinoids in Hemp Varieties Grown in Maryland

et al. 2021

View full text Add to dashboard Cite

Coincident with the cannabis legalization and the increased interest in the medicinal use of the plant, the cannabis marketplace and farming have seen tremendous growth. It is reported that there are more than 2000 cannabis varieties available to customers. However, the data that is available to the growers and breeders regarding the cannabinoid contents of various varieties remains low. Here, a high-performance liquid chromatography (HPLC) method was developed and validated for the simultaneous separation and determination of 11 cannabinoids. A total of 104 hemp bud materials belonging to 20 varieties were collected from farms in the state of Maryland and analyzed with the HPLC method. The contents of the 11 cannabinoids in various varieties were compared and discussed, highlighting the varieties that showed a high yield of cannabinoids and good consistency that are more appropriate for cannabinoid production.

show abstract

Medicalization without legalization: the European policy for medical and recreational cannabis use

Farber,

Nir,

Farber

2024

J Public Health (Berl.)

View full text Add to dashboard Cite

Aim Cannabis, unlike other illicit drugs, possesses medical properties. This unique characteristic necessitates a distinction between its clinical and legal status, prompting an inquiry into the nature of the relationship between these two dimensions. Countries are adopting one of three clinical policies regarding medical use (opposition, pharmaceuticalization, and medicalization) and one of three legal regimes regarding recreational use (prohibition, decriminalization, and legalization). This study examines the correlation between the clinical policy and the legal regime for cannabis in European countries. Subject and methods We used data from 39 European countries to classify every country’s clinical policy and legal regime. Then, we employed chi-squared and Spearman correlation tests to assess the relationships between the clinical and legal dimensions. Results The chi-squared test results indicate a strong and statistically significant relationship between the clinical policy for cannabis and the legal regime for recreational cannabis (p < 0.01). Spearman correlation test results also reveal a positive, strong, and significant relationship (p < 0.001). We found that medicalization as a clinical policy is associated with decriminalization as a legal regime (68% of medicalization countries decriminalize recreational use). Conclusion This study proposes a novel perspective that separates the concepts of medicalization and legalization, challenging previous assumptions about their interconnectedness. We argue that medicalization and decriminalization of cannabis are closely associated, likely because decriminalization facilitates patient access and fosters a medical cannabis market while avoiding the extremes of prohibition or full-scale legalization. These findings contribute to a more nuanced understanding of cannabis policy development in Europe and suggest that policymakers should consider the complex interplay between clinical and legal approaches when formulating cannabis policies. This research provides valuable insights for future policy discussions and highlights the need for further investigation into the long-term implications of these policy choices.

show abstract

The trajectory of “medical cannabis” in Israel: Driving medicalization in different directions

Cited by 9 publications

References 39 publications

Public perceptions of medical cannabis diversion: A legal and moral dilemma

Public perceptions of medical cannabis diversion: A legal and moral dilemma

Contents of Cannabinoids in Hemp Varieties Grown in Maryland

Medicalization without legalization: the European policy for medical and recreational cannabis use

Contact Info

Product

Resources

About